Literature DB >> 26656450

Variation in the CTLA4 3'UTR has phenotypic consequences for autoreactive T cells and associates with genetic risk for type 1 diabetes.

V M de Jong1, A Zaldumbide2, A R van der Slik1, S Laban1, B P C Koeleman3, B O Roep1.   

Abstract

Cytotoxic T-lymphocyte-associated protein 4 (CTLA4) is a protein receptor that downregulates the immune system. CTLA4 gene variants associate with various autoimmune diseases, including type 1 diabetes. Fine mapping of the genetic risk has shown that the genomic region near CTLA4 marked by the single-nucleotide polymorphism (SNP) CT60A/G (rs3087243) acts as a susceptibility factor. Yet, the functional basis for the increased susceptibility conferred by rs3087243 remains unclear. We demonstrate that the length of the dinucleotide (AT)n repeat within the CTLA4 3' untranslated region (3'UTR) strongly associates with the risk of SNP CT60A/G (P<6.5 × 10(-72)). Genomic (AT)n repeat length inversely correlated with CTLA4 messenger RNA (mRNA) and protein levels in islet autoreactive T-cell lines. Transfer of a long (AT)n element into T cells lead to a reduction of mRNA compared to a short (AT)n element. Thus, this study provides evidence for a role of the CTLA4 3'UTR (AT)n repeat in the increased genetic risk for islet autoimmunity associated with the CTLA4 locus.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26656450     DOI: 10.1038/gene.2015.51

Source DB:  PubMed          Journal:  Genes Immun        ISSN: 1466-4879            Impact factor:   2.676


  30 in total

1.  Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease.

Authors:  Hironori Ueda; Joanna M M Howson; Laura Esposito; Joanne Heward; Hywel Snook; Giselle Chamberlain; Daniel B Rainbow; Kara M D Hunter; Annabel N Smith; Gianfranco Di Genova; Mathias H Herr; Ingrid Dahlman; Felicity Payne; Deborah Smyth; Christopher Lowe; Rebecca C J Twells; Sarah Howlett; Barry Healy; Sarah Nutland; Helen E Rance; Vin Everett; Luc J Smink; Alex C Lam; Heather J Cordell; Neil M Walker; Cristina Bordin; John Hulme; Costantino Motzo; Francesco Cucca; J Fred Hess; Michael L Metzker; Jane Rogers; Simon Gregory; Amit Allahabadia; Ratnasingam Nithiyananthan; Eva Tuomilehto-Wolf; Jaakko Tuomilehto; Polly Bingley; Kathleen M Gillespie; Dag E Undlien; Kjersti S Rønningen; Cristian Guja; Constantin Ionescu-Tîrgovişte; David A Savage; A Peter Maxwell; Dennis J Carson; Chris C Patterson; Jayne A Franklyn; David G Clayton; Laurence B Peterson; Linda S Wicker; John A Todd; Stephen C L Gough
Journal:  Nature       Date:  2003-04-30       Impact factor: 49.962

2.  CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones.

Authors:  F A Harding; J G McArthur; J A Gross; D H Raulet; J P Allison
Journal:  Nature       Date:  1992-04-16       Impact factor: 49.962

Review 3.  Post-transcriptional control of cytokine production.

Authors:  Paul Anderson
Journal:  Nat Immunol       Date:  2008-04       Impact factor: 25.606

4.  CTLA4 is differentially associated with autoimmune diseases in the Dutch population.

Authors:  Alexandra Zhernakova; Peter Eerligh; Pilar Barrera; Joanna Z Wesoly; Joanna Z Weseloy; Tom W J Huizinga; Bart O Roep; Cisca Wijmenga; Bobby P C Koeleman
Journal:  Hum Genet       Date:  2005-07-16       Impact factor: 4.132

5.  Linkage disequilibrium of a type 1 diabetes susceptibility locus with a regulatory IL12B allele.

Authors:  G Morahan; D Huang; S I Ymer; M R Cancilla; K Stephen; P Dabadghao; G Werther; B D Tait; L C Harrison; P G Colman
Journal:  Nat Genet       Date:  2001-02       Impact factor: 38.330

6.  Likelihood-based association analysis for nuclear families and unrelated subjects with missing genotype data.

Authors:  Frank Dudbridge
Journal:  Hum Hered       Date:  2008-03-31       Impact factor: 0.444

7.  An autoimmune disease-associated CTLA-4 splice variant lacking the B7 binding domain signals negatively in T cells.

Authors:  Lalitha Vijayakrishnan; Jacqueline M Slavik; Zsolt Illés; Rebecca J Greenwald; Dan Rainbow; Bernhard Greve; Laurence B Peterson; David A Hafler; Gordon J Freeman; Arlene H Sharpe; Linda S Wicker; Vijay K Kuchroo
Journal:  Immunity       Date:  2004-05       Impact factor: 31.745

8.  Identification of CTLA-4 isoforms produced by alternative splicing and their association with myasthenia gravis.

Authors:  Ming Gu; Maria Kakoulidou; Ricardo Giscombe; Ritva Pirskanen; Ann Kari Lefvert; Lars Klareskog; XiongBiao Wang
Journal:  Clin Immunol       Date:  2008-07-02       Impact factor: 3.969

9.  CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation.

Authors:  M F Krummel; J P Allison
Journal:  J Exp Med       Date:  1995-08-01       Impact factor: 14.307

10.  CTLA-4 suppresses the pathogenicity of self antigen-specific T cells by cell-intrinsic and cell-extrinsic mechanisms.

Authors:  Wataru Ise; Masako Kohyama; Katherine M Nutsch; Hyang Mi Lee; Anish Suri; Emil R Unanue; Theresa L Murphy; Kenneth M Murphy
Journal:  Nat Immunol       Date:  2009-12-27       Impact factor: 25.606

View more
  14 in total

Review 1.  Genetic Risk Scores for Type 1 Diabetes Prediction and Diagnosis.

Authors:  Maria J Redondo; Richard A Oram; Andrea K Steck
Journal:  Curr Diab Rep       Date:  2017-10-28       Impact factor: 4.810

2.  Tremelimumab-Induced Graves Hyperthyroidism.

Authors:  Earn H Gan; Anna L Mitchell; Ruth Plummer; Simon Pearce; Petros Perros
Journal:  Eur Thyroid J       Date:  2017-03-14

Review 3.  Genetics of type 1 diabetes.

Authors:  Maria J Redondo; Andrea K Steck; Alberto Pugliese
Journal:  Pediatr Diabetes       Date:  2017-11-02       Impact factor: 4.866

4.  Dominant TNFα and impaired IL-2 cytokine profiles of CD4+ T cells from children with type-1 diabetes.

Authors:  Julia Seyfarth; Katharina Förtsch; Heinz Ahlert; Hans-Juergen Laws; Beate Karges; Rene Deenen; Karl Köhrer; Ertan Mayatepek; Thomas Meissner; Marc Jacobsen
Journal:  Immunol Cell Biol       Date:  2017-04-05       Impact factor: 5.126

5.  High-yield genome engineering in primary cells using a hybrid ssDNA repair template and small-molecule cocktails.

Authors:  Brian R Shy; Vivasvan S Vykunta; Alvin Ha; Alexis Talbot; Theodore L Roth; David N Nguyen; Wolfgang G Pfeifer; Yan Yi Chen; Franziska Blaeschke; Eric Shifrut; Shane Vedova; Murad R Mamedov; Jing-Yi Jing Chung; Hong Li; Ruby Yu; David Wu; Jeffrey Wolf; Thomas G Martin; Carlos E Castro; Lumeng Ye; Jonathan H Esensten; Justin Eyquem; Alexander Marson
Journal:  Nat Biotechnol       Date:  2022-08-25       Impact factor: 68.164

Review 6.  Alopecia areata: Animal models illuminate autoimmune pathogenesis and novel immunotherapeutic strategies.

Authors:  Amos Gilhar; Adam G Schrum; Amos Etzioni; Herman Waldmann; Ralf Paus
Journal:  Autoimmun Rev       Date:  2016-03-10       Impact factor: 9.754

Review 7.  Obstacles and opportunities for targeting the effector T cell response in type 1 diabetes.

Authors:  Jane H Buckner; Gerald T Nepom
Journal:  J Autoimmun       Date:  2016-03-03       Impact factor: 7.094

8.  Genetic influences on susceptibility to rheumatoid arthritis in African-Americans.

Authors:  Vincent A Laufer; Hemant K Tiwari; Richard J Reynolds; Maria I Danila; Jelai Wang; Jeffrey C Edberg; Robert P Kimberly; Leah C Kottyan; John B Harley; Ted R Mikuls; Peter K Gregersen; Devin M Absher; Carl D Langefeld; Donna K Arnett; S Louis Bridges
Journal:  Hum Mol Genet       Date:  2019-03-01       Impact factor: 6.150

9.  Pathogenic implications for autoimmune mechanisms derived by comparative eQTL analysis of CD4+ versus CD8+ T cells.

Authors:  Silva Kasela; Kai Kisand; Liina Tserel; Epp Kaleviste; Anu Remm; Krista Fischer; Tõnu Esko; Harm-Jan Westra; Benjamin P Fairfax; Seiko Makino; Julian C Knight; Lude Franke; Andres Metspalu; Pärt Peterson; Lili Milani
Journal:  PLoS Genet       Date:  2017-03-01       Impact factor: 5.917

10.  CTLA-4 Genetic Variants (rs11571317 and rs3087243): Role in Susceptibility and Progression of Breast Cancer.

Authors:  Maruthi Goske; V R Vinish Ramachander; Prasanna Latha Komaravalli; P Fazul Rahman; Chandrasekhar Rao; Parveen Jahan
Journal:  World J Oncol       Date:  2017-11-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.